Form 6-K NOVARTIS AG For: Dec 31

Go back to Form 6-K NOVARTIS AG For: Dec 31

Novartis (NVS) Reports In-Line Q3 EPS of $1.21; Guides FY15 Sales Growth

January 27, 2015 7:47 AM EST

Novartis (NYSE: NVS) reported Q3 EPS of $1.21, in-line with the analyst estimate of $1.21. Revenue for the quarter came in at $14.63 billion versus the consensus estimate of $14.68 billion.

Strong innovation momentum continues from... More